Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). uri icon

authors

  • Femminella, Grazia Daniela
  • Ridha, Basil H
  • Bannister, Carol
  • Walker, Zuzana
  • Archer, Hilary
  • Coulthard, Elizabeth
  • Underwood, Ben R
  • Prasanna, Aparna
  • Koranteng, Paul
  • Karim, Salman
  • Junaid, Kehinde
  • Frangou, Eleni
  • Bernadette McGuinness, MD, PhD
  • Nilforooshan, Ramin
  • Macharouthu, Ajay
  • Donaldson, Andrew
  • Thacker, Simon
  • Russell, Gregor
  • Malik, Naghma
  • Mate, Vandana
  • Knight, Lucy
  • Kshemendran, Sajeev
  • Love, Sharon B
  • Harrison, John
  • Hölscher, Christian
  • Brooks, David J
  • Passmore, Anthony Peter
  • Ballard, Clive
  • Edison, Paul
  • Busza, Gail
  • Holmes, Clive
  • Ritchie, Craig
  • Lawrence, Robert
  • McFarlane, Brady
  • Tadros, George

publication date

  • January 1, 2019

published in